The effect of antioxidant supplementation on the oxidant and antioxidant status in sickle cell Anaemia

Journal of Clinical and Diagnostic Research

Volumn 5, Issue 7, 2012, Pages 1339-1342

  Hundekar, Prakash S ^a   Suryakar, Aadinath N ^b   Karnik, Aarti C ^a   Valvi, Rajesh ^c   Ghone, Rahul A ^a   Bhagat, Sonali S ^d  

^a ACPM Medical College   (India)

^b MAHARASHTRA UNIVERSITY OF HEALTH SCIENCES   (India)

^c Civil Hospital and Medicare Hospital   (India)

^d Dept of Biochemistry   (India)

Author keywords

Nitric oxide; Oxidative stress; Sickle cell anaemia; Superoxide dismutase; TAC of plasma

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; CATALASE; FREE RADICAL; LIPID PEROXIDE; MALONALDEHYDE; NITRIC OXIDE; PROTEIN CARBONYL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANALYTICAL PARAMETERS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEMATOPOIESIS; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PATHOGENESIS; SICKLE CELL ANEMIA; TOTAL ANTIOXIDANT CAPACITY OF PLASMA;

EID: 84861561281     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kate SL, Lingojwar DP. The epidemiology of sickle cell disorder in the state of Maharashtra. Int J Hum Genet 2002; 2: 161-67.
2. Hebbel RP, Eaton JW, Balasingam M, Steinberg MH. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 1982; 70: 1253-59.
3. Rice-Evans C, Omorphos SC, Baysal E. Sickle cell membranes and oxidative damage. Biochem J 1986; 237: 265-69.
4. Satoh K. Serum lipid peroxide in cerebrovascular disorders which was determined by a new colorimetric method. Clinica Chemica Acta 1978; 90: 37-43.
5. Levine RL, Willium JA, Stadtman ER. Carbonyl assays for the deter mination of oxidatively modified proteins. Methods Enzymol 1994; 233:346-57.
6. Cortas NK, Wakid NW. The determination of inorganic nitrate in serum and urine by the kinetic cadmium reduction method. Clinical Chemistry 1990; 36:1440-43.
7. Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. Lab Gun Med 1975; 85: 337-41.
8. Goth L. A simple method for the determination of the serum catalase activity and the revision of the reference range. Clinica Chimica Acta 1991; 196:143-45.
9. Benzie IFF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 1996; 239:70-76.
10. Titus J, Chari S, Gupta M, Parekh N. Pro-oxidant and anti-oxidant status in patients of sickle cell anaemia. Indian Journal Clinical Biochemistry 2004; 19: 168-72.
11. Das SK, Nair RC. Superoxide dismutase, glutathione peroxidase, catalase, and the lipid peroxidation of normal and sickled erythrocytes. Br J Haematol 1980; 44: 87-92.
12. Kuross SA, Hebbel RP. Nonheme iron in sickle erythrocyte membranes: association with phospholipids and potential role in lipid peroxidation. Blood 1988; 72:1278-85.
13. Asakura T, Minakata K, Adachi K, Russell MO, Schwartz E. Denatured hemoglobin in sickled erythrocytes. J Clin Invest 1977; 59: 633-40.
14. Hongmei R, Ghebremeskel K, Okpala. Patients with sickle cell anaemia have reduced antioxidant production. Int J Vitam Nutr Res 2008; 78:139-47.
15. Schacter L, Warth JA, Gordon EM, Prasad AS, Klein BL. Altered amount and activity of superoxide dismutase in sickle cell anemia. FASEB 1988; 2: 237-43.
16. Scott MD, Eaton JW, Chiu DT-Y, Kuypers FA, Lubin B. Enhancement of the erythrocyte superoxide dismutase activity: effect on cellular oxidant defense. Blood 1989; 74:2542-49.
17. Adelekan DA, Thurnham DI, Adekile AD. Reduced antioxidant capacity in pediatric patients with homozygous sickle cell disease. Eur J of Clin Nutr 1989; 43:609-14. 1341
18. Hasanato RMW. Zinc and antioxidant vitamin deficiency in patients with severe sickle cell anemia. Ann Saudi Med 2006; 26: 17-22.
19. Essien EU. Plasma levels of retinol, ascorbic acid and alpha-tocopherol in sickle cell anemia. Cent Afr J Med 1995; 41:48-50.
20. Gupta VL, Chaubey BS. Efficacy of zinc therapy in the prevention of a crisis in sickle cell anemia a double - blind randomized controlled clinical trial. J Assoc Physicians India 1995; 43: 467-69.
21. Serjeant OR, Serjeant BE, Milner PF. The irreversibly sickled cell; a determinant of haemolysis in sickle cell anemia. Brit J Haematol 1969; 17: 527-33.
22. Huang HY, Appel LJ, Croft KD, Miller ER III, Mori TA, Puddey IB. Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial. Am J Clin Nutr 2002; 76:549-55.
23. Natta, Lawrence. Plasma levels of tocopherol in sickle cell anemia subjects. Am J Clin Nutr 1979; 32: 1359-62.
24. Muskiet FA, Muskiet FD, Meiborg G, Schermer JG. Supplementation of patients with homozygous sickle cell disease with zinc, a-tocopherol, vitamin c, soybean oil, and fish oil. Am J Clin Nutr 1991; 54:736-44.
25. Lachant NA, Tanaka KR. Antioxidants in sickle cell disease: the in vitro effects of ascorbic acid. Am J Med Sci 1986; 292:3-l0.